Vanda Pharmaceuticals (VNDA) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-17.41M
Depreciation and amortization
Employee and non-employee stock-based compensation	6.44M
Loss on disposal of assets
Amortization of premiums and discounts on marketable securities	76K
Amortization of intangible asset	8.83M
Deferred tax benefit
Accounts receivable	52K
Inventory	63K
Prepaid expenses, deposits and other current assets	-5.4M
Accounts payable
Accrued liabilities
Accrued income taxes
Other liabilities
Deferred revenue
Net cash used in operating activities
Purchases of property and equipment	-710K
Proceeds from sale of property and equipment
Purchases of marketable securities	-130.86M
Maturities of marketable securities
Change in restricted cash
Net cash provided by (used in) investing activities
Excess tax benefits from stock-based compensation
Proceeds from exercise of stock options
Net cash provided by financing activities
Net change in cash and cash equivalents	-18.08M
Beginning of period	50.84M
End of period	32.77M

Entities mentioned with VNDA

View All Entities